In the
study,
USC Stem Cell researcher Casey Brewer and colleagues in the laboratory of Rong Lu found that transplantation dose affects the behavior of blood - forming stem cells in bone marrow — called hematopoietic stem cells, or H
Stem Cell researcher Casey Brewer and colleagues in the laboratory of Rong Lu found that transplantation dose affects the behavior of blood - forming
stem cells in bone marrow — called hematopoietic stem cells, or H
stem cells in bone marrow — called hematopoietic
stem cells, or H
stem cells, or HSCs.
«This is the first human trial of this novel
stem cell - based implant, which is designed to replace a single -
cell layer that degenerates in patients with dry age - related macular degeneration,» says lead author and surgeon for the
study Dr. Amir H. Kashani, assistant professor of clinical ophthalmology at the Keck School of Medicine of
USC.
«Our
study shows that this unique
stem cell - based retinal implant thus far is well - tolerated, and preliminary results suggest it may help people with advanced dry age - related macular degeneration,» says coauthor and lead inventor of the implant Dr. Mark S. Humayun, MD, director of the USC Institute for Biomedical Therapeutics, co-director of the USC Roski Eye Institute, affiliate principal investigator with the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC and university professor of ophthalmology at the Keck Sch
stem cell - based retinal implant thus far is well - tolerated, and preliminary results suggest it may help people with advanced dry age - related macular degeneration,» says coauthor and lead inventor of the implant Dr. Mark S. Humayun, MD, director of the USC Institute for Biomedical Therapeutics, co-director of the USC Roski Eye Institute, affiliate principal investigator with the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC and university professor of ophthalmology at the Keck Sch
cell - based retinal implant thus far is well - tolerated, and preliminary results suggest it may help people with advanced dry age - related macular degeneration,» says coauthor and lead inventor of the implant Dr. Mark S. Humayun, MD, director of the
USC Institute for Biomedical Therapeutics, co-director of the
USC Roski Eye Institute, affiliate principal investigator with the Eli and Edythe Broad Center for Regenerative Medicine and
Stem Cell Research at USC and university professor of ophthalmology at the Keck Sch
Stem Cell Research at USC and university professor of ophthalmology at the Keck Sch
Cell Research at
USC and university professor of ophthalmology at the Keck School.